Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women

January 4, 2024 updated by: Christiana Care Health Services

Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women: Addressing Social Needs and Improving Health Outcomes

The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. The pilot study has three specific aims:

Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed

Aim 2: To determine the prevalence of and change in social needs

Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care

Study Overview

Detailed Description

This study is a pilot randomized controlled trial where eligible pregnant ChristianaCare patients will be identified weekly through an automated list, and patients who consent will be randomized to 1 of 2 arms (Women's Health Delaware Food Farmacy vs. usual standard of care). Participants randomized to the Women's Health Delaware Food Farmacy program arm will receive medically tailored groceries that are high in micronutrients critical for a healthy pregnancy. The food provided will be the equivalent of 10 meals per person in the household per week and will be delivered to participants weekly from enrollment to 4 weeks after giving birth. Participants will receive culinary equipment and training, recipes, and educational nutrition videos and will interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Participants randomized to the usual standard of care arm will continue to receive their standard of care management.

All participants will complete a questionnaire with patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) at baseline and postpartum and a patient experience survey postpartum related to their experiences receiving prenatal care and giving birth at ChristianaCare. In addition, maternal and child health, healthcare utilization, and clinical event outcomes will be documented for all participants via electronic health records and assessed retrospectively. Quantitative indicators related to feasibility (i.e., acceptability, demand, and implementation) will be collected such as program satisfaction, program enrollment and retention, meals provided to participants and their household, food consumption, and interactions with assigned Community Health Worker.

Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed

H1. Primary outcomes. The investigators hypothesize that the Women's Health Delaware Food Farmacy will: (a) prove acceptable to participants, as measured by program satisfaction; (b) meet demand, as measured by project recruitment and retention, number of meals provided to participants and their household, and number of people providing food for; and (c) prove implementable, as measured by food consumption, number of Community Health Worker interactions, number of educational videos watched, number of recipes reviewed, and number of meal preparation sessions.

Aim 2: To determine the prevalence of and change in social needs

H2. Primary outcome. Social needs will be identified by administering the ChristianaCare Social Determinants of Health Screener and resource referrals will be sent on participants' behalf to support their social needs, both of which are the usual standard of care. The investigators hypothesize that social needs will be identified through the ChristianaCare Social Determinants of Health Screener, and that compared to baseline, participants at postpartum will experience reductions in their social needs. The investigators also hypothesize there will be some participants whose social needs will not be resolved due to a lack of community resources.

Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care

H3a. Primary outcomes. Maternal and child health outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in maternal and child health outcomes (e.g., preeclampsia and small for gestational age) from baseline to postpartum.

H3b. Primary outcomes. Maternal and child healthcare utilization outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child healthcare utilization outcomes (e.g., neonatal intensive care unit [NICU] admission and maternal length of stay) from baseline to postpartum.

H3c. Primary outcomes. Maternal and child clinical event outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child clinical event outcomes (e.g., cesarean delivery and fetal death) from baseline to postpartum.

H3d. Secondary outcomes. Patient-reported outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) from baseline to postpartum.

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Delaware
      • Newark, Delaware, United States, 19718
        • Recruiting
        • ChristianaCare Christiana Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ChristianaCare Women's Health patient
  • 18 years or older
  • 4 to 14 weeks pregnant
  • Singleton pregnancy
  • Medicaid
  • BMI of 30 or higher
  • Reside in New Castle County

Exclusion Criteria:

  • Current diagnosis of type 1 or type 2 diabetes
  • Multiple pregnancy
  • Currently enrolled in another Community Health Worker program
  • Not able to store and prepare meals
  • Diagnosed with severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Women's Health Delaware Food Farmacy
Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.
Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.
Active Comparator: Usual Standard of Care
Participants will receive the usual standard of care.
Participants will receive the usual standard of care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Determinants of Health
Time Frame: Changes from baseline to 2-6 weeks after delivery
Measured with ChristianaCare Social Determinants of Health Screener; Number of socials needs range from 0-11, higher scores indicate greater number of social needs
Changes from baseline to 2-6 weeks after delivery
Gestational Weight Gain
Time Frame: Changes from baseline to 2-6 weeks after delivery
Observed gestational weight gained
Changes from baseline to 2-6 weeks after delivery
Body Mass Index
Time Frame: Changes from baseline to 2-6 weeks after delivery
Observed body mass index changes
Changes from baseline to 2-6 weeks after delivery
Gestational Diabetes
Time Frame: From baseline to delivery
Occurrence of gestational diabetes
From baseline to delivery
Gestational Hypertension
Time Frame: From baseline to delivery
Occurrence of gestational hypertension
From baseline to delivery
Systolic and Diastolic Blood Pressure
Time Frame: Changes from baseline to 2-6 weeks after delivery
Observed systolic and diastolic blood pressure
Changes from baseline to 2-6 weeks after delivery
Preeclampsia
Time Frame: From baseline to 2-6 weeks after delivery
Occurrence of preeclampsia and week diagnosed during pregnancy
From baseline to 2-6 weeks after delivery
Hydramnios
Time Frame: From baseline to delivery
Occurrence of hydramnios
From baseline to delivery
Gestational Age
Time Frame: At delivery
Baby's gestational age at birth
At delivery
Small for Gestational Age
Time Frame: At delivery
Birth weight less than 10th percentile based on gestational age
At delivery
Preterm Birth
Time Frame: At delivery
Preterm birth less than 37 weeks
At delivery
Fetal Macrosomia
Time Frame: At delivery
Birth weight greater than 90th percentile based on gestational age
At delivery
Cesarean Delivery
Time Frame: At delivery
Occurrence of cesarean delivery including those planned and unplanned
At delivery
Fetal Death
Time Frame: From baseline to delivery
Occurrence of fetal death
From baseline to delivery
NICU Admission
Time Frame: Within 48 hours after delivery
Occurrence of NICU admission for any reason
Within 48 hours after delivery
NICU Length of Stay
Time Frame: From NICU admission date to NICU discharge date, assessed up to 90 days
Number of days baby was admitted to NICU
From NICU admission date to NICU discharge date, assessed up to 90 days
Maternal Length of Stay
Time Frame: From delivery date to hospital discharge date, assessed up to 90 days
Number of days hospitalized following delivery
From delivery date to hospital discharge date, assessed up to 90 days
Postpartum Admission
Time Frame: From delivery discharge to 90 days after
Number of postpartum hospital admissions for any reason
From delivery discharge to 90 days after
Postpartum Admission Length of Stay
Time Frame: From postpartum admission date to hospital discharge date, assessed up to 90 days
Number of days hospitalized
From postpartum admission date to hospital discharge date, assessed up to 90 days
Hospital Admission
Time Frame: From baseline up to delivery
Number of hospital admissions for any reason
From baseline up to delivery
Hospital Admission Length of Stay
Time Frame: From admission date to hospital discharge date, assessed up to 90 days
Number of days hospitalized
From admission date to hospital discharge date, assessed up to 90 days
Emergency Room Visit
Time Frame: From baseline to 90 days after delivery
Number of emergency room visits for any reason
From baseline to 90 days after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food Insecurity
Time Frame: Changes from baseline to 2-6 weeks after delivery
Measured with United States Department of Agriculture Household Food Security Survey Module 6-Item Short Form, 30-day; Scores range from 0-6, higher scores indicate lower food security
Changes from baseline to 2-6 weeks after delivery
Dietary Intake
Time Frame: Changes from baseline to 2-6 weeks after delivery
Measured with Dietary Screener Questionnaire (DSQ-10) and six items from Dietary Screener Questionnaire (DSQ-26); Scores will be calculated using the National Cancer Institute's scoring algorithms
Changes from baseline to 2-6 weeks after delivery
Health-Related Quality of Life
Time Frame: Changes from baseline to 2-6 weeks after delivery
Measured with Centers for Disease Control and Prevention's Health-Related Quality of Life (HRQOL-4) scale; Number of healthy days range from 0-30, higher scores indicate greater number of healthy days
Changes from baseline to 2-6 weeks after delivery
Cost-Related Medication Underuse
Time Frame: Changes from baseline to 2-6 weeks after delivery
Measured with Cost-Related Medication Underuse; Scores range from 0-4, scores greater than 0 indicate cost-related medication underuse
Changes from baseline to 2-6 weeks after delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2024

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

December 6, 2023

First Submitted That Met QC Criteria

December 19, 2023

First Posted (Actual)

December 26, 2023

Study Record Updates

Last Update Posted (Actual)

January 8, 2024

Last Update Submitted That Met QC Criteria

January 4, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Women's Health Delaware Food Farmacy

3
Subscribe